When medication fails: Neurostimulation therapies for depression

Clinical Neuropsychiatry

Volumn 8, Issue 1, 2011, Pages 61-80

  Carpenter, Linda L ^a   Megna, James L ^b   Herrera Rojas, Mariela ^b   Siddiqui, Umar A ^b  

^a BROWN UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Neurostimulation techniques; Pharmacotherapy interventions; Resistant

Indexed keywords

BRAIN DEPTH STIMULATION; BRAIN REGION; CONVULSIVE THERAPY; DEPRESSION; DRUG TREATMENT FAILURE; ELECTROCONVULSIVE THERAPY; EPIDURAL PREFRONTAL CORTICAL STIMULATION; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; MAGNETIC SEIZURE THERAPY; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; REVIEW; THERAPY EFFECT; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 79955618048     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (265)

1. Abosch A and A Lozano (2003). Stereotactic neurosurgery for movement disorders. Can J Neurol Sci 30, Suppl I, S72-82.
2. Ahdab R et al. (2010). Comparison of standard and navigated procedures of TMS coil positioning over motor premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol Clin 40, 1, 27-36.
3. Anderson B et al. (2006). Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J Ect 22, 1, 49-53.
4. Anttila S et al. (2008). Catechol-O-methyltransferase COMT polymorphisms predict treatment response in electroconvulsive therapy. Pharmacogenomics t 8, 2, 1136.
5. Arul-Anandam AP, C Loo and P Mitchell (2010). Induction of hypomanic episode with transcranial direct current stimulation. J Ect 26, 1, 68-9.
6. Avery DH et al. (2006). A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 59, 2, 187-94.
7. Avery DH et al. (2008). Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder, Clinical Response in an Open-Label Extension Trial. J Clin Psychiatry e1-e11.
8. Bailey P and F Bremer (1938). A sensory cortical representation of the vagus nerve, with a note on the effects of low blood pressure on the cortical electrogram. Journal of Neurophysiology 1, 405-12.
9. Ballenger JC and RM Post (1980). Carbamazepine in manic-depressive illness, a new treatment. Am tPsychiatry 137, 7, 782-90.
10. Bajbouj M et al. (2006). Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. JPsychiatr Res 40, 4, 322-7.
11. Bajbouj M et al. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 30, 3, 273-81.
12. Barker AT and MW Cain (1985). The claimed vasodilatory effect of a commercial permanent magnet foil, results of a double-blind trial. Clin Phys Physiol Meas 6, 3, 261-3.
13. Bayless JD et al. (2010). Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression, relationship to premorbid abilities and symptom improvement. J Ect 26, 1, 47-52.
14. Beam W et al. (2009). An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul 2, 1, 50-4.
15. Benabid AL et al. (1987). Combined thalamotomy and stimulation stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50, 1-6, 344-6.
16. Ben-Menachem E et al. (1994). Vagus nerve stimulation for treatment of partial seizures, 1 A controlled study of effect on seizures First International Vagus Nerve Stimulation Study Group. Epilepsia 35, 3, 616-26.
17. Ben-Menachem E et al. (1995). Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 20, 3, 221-7.
18. Ben-Menachem E (2001). Vagus nerve stimulation side effects and long-term safety. J Clin Neurophysiol 18, 5, 415-8.
19. Ben-Shachar D et al. (1997). Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm 104, 2-3, 191-7.
20. Berman RM et al. (2008). Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy. Brain Stimul 1, 1, 16-26.
21. Beurrier C et al. (2001). High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. JNeurophysiol 85, 4, 1351-6.
22. Bewernick BH et al. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67, 2, 110-6.
23. Bickford RG et al. (1987). Magnetic stimulation of human peripheral nerve and brain, response enhancement by combined magnetoelectrical technique. Neurosurgery 20, 1, 110-6.
24. Boggio PS et al. (2008). A randomized double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int t Neuro-psychopharmacol 11, 2, 249-54.
25. Bremner JD et al. (1997). Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54, 4, 364-74.
26. Bretlau LG et al. (2008). Repetitive Transcranial Magnetic Stimulation rTMS in Combination with Escitalopram in Patients with Treatment-Resistant Major Depression A Double-Blind Randomised Sham-Controlled Trial. Pharmacopsychiatry 41, 2, 41-7.
27. Burke WJ and FA Moreno (2006). Suicidality in treatment-resistant depression, results from a 24-month trial of vagus nerve stimulation in 156th American Psychiatric Association Annual Meeting, Toronto, Canada.
28. Burke MJ and MM Husain (2006). Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J Ect 22, 3, 218-22.
29. Burt T, SH Lisanby and HA Sackeim (2002). Neuropsychiatric applications of transcranial magnetic stimulation, a meta analysis. Int t Neuropsychopharmacol 5, 1, 73-103.
30. Calabrese Jr et al. (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression Lamictal 602 Study Group. J Clin Psychiatry 60, 2, 79-88.
31. Calev A et al. (1991). Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis 179, 9, 52633.
32. Carpenter LL et al. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites norepinephrine and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 56, 6, 418-26.
33. Carpenter LL et al. (2008). Decreased cerebrospinal fluid concentrations of substance pin treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Res 157, 1-3, 123-9.
34. Chae JH et al. (2003). A review of functional neuroimaging studies of vagus nerve stimulation VNS. J Psychiatr Res 37, 6, 443-55.
35. Chen R et al. (1997). Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48, 5, 1398-403.
36. Chistyakov AV et al. (2010). Safety tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. Int t Neuropsychopharmacol 13, 3, 387-93.
37. Cohen H et al. (2004). Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder, a double-blind placebo-controlled study. Am tPsychiatry 161, 3, 515-24.
38. Conway CR et al. (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res 146, 179-84.
39. Corcoran CD et al. (2006). Vagus nerve stimulation in chronic treatment-resistant depression, preliminary findings of an open-label study. Br t Psychiatry 189, 282-3.
40. Criado JM, A Fernandez and T Ortiz (2007). Long-term effects of electroconvulsive therapy on episodic memory. Actas Esp Psiquiatr 35, 1, 40-6.
41. Cycowicz YM et al. (2009). Neurophysiological characterization of high-dose magnetic seizure therapy, comparisons with electroconvulsive shock and cognitive outcomes. J Ect 25, 157-64.
42. Dannon PN et al. (2002). Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals-preliminary report. Biol Psychiatry 51, 8, 687-90.
43. Dell Pand, R Olson (1951) Secondary mesencephalic diencephalic and amygdalian projections of vagal visceral afferences. C R Seances Soc Biol Fil 145, 13-14, 1088-91.
44. Demitrack MA (2007). The use and clinical significance of transcranial magnetic stimulation in the treatment of major depression. Psychopharm Review 42, 6, 43-50.
45. Demitrack MA and ME (2009). Thase Clinical significance of transcranial magnetic stimulation TMS in the treatment of pharmacoresistant depression, synthesis of recent data. Psychopharmacol Bull 42, 2, 5-38.
46. De Murtas M et al. (2004). Repeated electroconvulsive stimulation impairs long-term depression in the neostriatum. Biol Psychiatry 55, 5, 472-6.
47. Dlabac-de Lange JJ, R Knegtering and A Aleman (2010). Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia, review and meta-analysis. J Clin Psychiatry 71, 4, 411-8.
48. Dodick DW et al. (2010). Transcranial magnetic stimulation for migraine, a safety review. Headache 50, 7, 1153-63.
49. Dolberg OT, S Schreiber and L Grunhaus (2001). Transcranial magnetic stimulation-induced switch into mania, a report of two cases. Biol Psychiatry 49, 5, 468-70.
50. Domschke K et al. (2010). COMT val158met influence on electroconvulsive therapy response in major depression. Am J Med Genet B Neuropsychiatr Genet 153B, 1, 28690.
51. Dorr AE and G Debonnel (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 318, 2, 890-8.
52. Ebert D et al. (1994). Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 55, 2, 101-9.
53. Elahi B and R Chen (2009). Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Mov Disord 24, 3, 35763.
54. Elger G et al. (2000). Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 42, 2-3, 203-10.
55. Epstein CM et al. (1990). Localizing the site of magnetic brain stimulation in humans. Neurology 40, 4, 666-70.
56. Esel E et al. (2008). The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J Ect 24, 3, 224-8.
57. Fahy BG (2010). Intraoperative and perioperative complications with a vagus nerve stimulation device. J Clin Anesth 22, 3, 213-22.
58. Faraday M (1839). Experimental Research in Electricity Quartich.
59. Fava M (2003). Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53, 8, 649-59.
60. Feliu M et al. (2008). Neuropsychological effects and attitudes in patients following electroconvulsive therapy. Neuropsychiatr Dis Treat 4, 3, 613-7.
61. Fierro B et al. (2001). Modulation of intracortical inhibition induced by low- and high-frequency repetitive transcranial magnetic stimulation. Exp Brain Res 138, 4, 452-7.
62. Fitzgerald PB et al. (2006). A randomized controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 163, 1, 88-94.
63. Fitzgerald PB et al. (2007). A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression. J Clin Psychopharmacol 27, 5, 488-92.
64. Fitzgerald PB et al. (2008). Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression. J Clin Psychopharmacol 28, 1, 52-8.
65. Fitzgerald PB et al. (2009a). A randomized trial ofrTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 34, 5, 1255-62.
66. Fitzgerald PB et al. (2009b). Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments. Brain Stimul 2, 4, 234-7.
67. Fitzgerald PB et al. (2009c). A study of the effectiveness of high-frequency left prefrontal cortex transcranial magnetic stimulation in major depression in patients who have not responded to right-sided stimulation. Psychiatry Res 169, 1, 12-5.
68. Fitzgerald PB et al. (2009d). A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress Anxiety 26, 3, 229-34.
69. Frais AT (2010). Electroconvulsive therapy, a theory for the mechanism of action. J Ect 26, 1, 60-1.
70. Fregni F et al. (2006). Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 8, 2, 203-4.
71. Fujita A et al. (2006). Memory attention and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. J Ect 22, 2, 107-12.
72. Gabriels L et al. (2003). Deep brain stimulation for treatment-refractory obsessive-compulsive disorder, psycho-pathological and neuropsychological outcome in three cases. Acta Psychiatr Scand 107, 4, 275-82.
73. Gagne GG Jr et al. (2000). Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157, 12, 1960-5.
74. Garcia KS et al. (2010). Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul 3, 1, 3641.
75. Garcia-Toro M et al. (2006). High 20-Hz and low 1-Hz frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res 146, 1, 537.
76. Garnett ES et al. (1992). Regional cerebral blood flow in man manipulated by direct vagal stimulation Pacing. Clin Electrophysiol 15, 10, Pt 2, 1579-80.
77. George MS et al. (1995). Daily repetitive transcranial magnetic stimulation rTMS improves mood in depression. Neuroreport 6, 14, 1853-6.
78. George MS et al. (1997). Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression, a placebo-controlled crossover trial. Am J Psychiatry 154, 12, 1752-6.
79. George MS et al. (2000). Vagus nerve stimulation, a new tool for brain research and therapy. Biol Psychiatry 47, 4, 28795.
80. George MS et al. (2002). Mechanisms and state of the art of transcranial magnetic stimulation. J Ect 18, 4, 170-81.
81. George MS et al. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58, 5, 364-73.
82. George MS et al. (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder, a sham-controlled randomized trial. Arch Gen Psychiatry 67, 5, 507-16.
83. Gershon AA, PN Dannon and L Grunhaus (2003). Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 160, 5, 835-45.
84. Giacobbe P and SH Kennedy (2006) Deep brain stimulation for treatment-resistant depression, a psychiatric perspective. Curr Psychiatry Rep 8, 6, 437-44.
85. Greenberg BD and AR Rezai (2003). Mechanisms and the current state of deep brain stimulation in neuropsychiatry. CNS Spectr 8, 7, 522-6.
86. Greenberg BD et al. (2004). Deep brain stimulation, clinical findings in intractable depression and OCD in American College Neuropsychopharmacology 43rd Annual Meeting, San Juan, Puerto Rico.
87. Greenberg BD et al. (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 31, 11, 2384-93.
88. Greenberg BD et al. (2008). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder, worldwide experience. Mol Psychiatry 15, 1, 116.
89. Grill WM, AN Snyder and S Miocinovic (2004). Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport 15, 7, 1137-40.
90. Gross M et al. (2007). Has repetitive transcranial magnetic stimulation rTMS treatment for depression improved? A systematic review and meta-analysis comparing the recent vs the earlier rTMS studies. Acta Psychiatr Scand 116, 3, 165-73.
91. Grossheinrich N et al. (2009). Theta burst stimulation of the prefrontal cortex, safety and impact on cognition mood and resting electroencephalogram. Biol Psychiatry 65, 9, 778-84.
92. Grunhaus L et al. (2003). A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 53, 4, 324-31.
93. Gupta S et al. (2008). Efficacy of maintenance electroconvulsive therapy in recurrent depression, a naturalistic study. J Ect 24, 3, 191-4.
94. Handforth A et al. (1998). Vagus nerve stimulation therapy for partial-onset seizures, a randomized active-control trial. Neurology 51, 1, 48-55.
95. Hansen PE et al. (2010). Low-Frequency Repetitive Transcranial Magnetic Stimulation Inferior to Electroconvulsive Therapy in Treating Depression. J Ect 27, 1, 26-32.
96. Harden CL et al. (2000). A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation. Epilepsy Behav 1, 2, 93-99.
97. Hargreaves GA, IS McGregor and PS Sachdev (2005). Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression. Psychiatry Res 137, 1-2, 113-21.
98. Henry TR (2000). Functional imaging studies of epilepsy therapies. Adv Neurol 83, 305-17.
99. Henry TR et al. (1998a). Vagus nerve stimulation-induced cerebral blood flow changes differ in acute and chronic therapy of complex partial seizure. Epilepsia 39, Suppl 6, 92.
100. Henry TR et al. (1998b). Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy, I Acute effects at high and low levels of stimulation. Epilepsia 39, 9, 983-90.
101. Henry TR et al. (1999). Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 52, 6, 1166-73.
102. Herbsman T et al. (2009). More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 66, 5, 509-15.
103. Herwig U et al. (2001a). The navigation of transcranial magnetic stimulation. Psychiatry Res 108, 2, 123-31.
104. Herwig U et al. (2001b). Transcranial magnetic stimulation in therapy studies, examination of the reliability of standard coil positioning by neuronavigation. Biol Psychiatry 50, 1, 58-61.
105. Hoflich G et al. (1993). Application of transcranial magnetic stimulation in treatment of drug-resistant major depression - a report of two cases. Human Psychopharmacology, Clinical and Experimental 8, 5, 361-365.
106. Holtzheimer PE et al. (2004). Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety 19, 1, 24-30.
107. Hoy KE and PB Fitzgerald (2010). Brain stimulation in psychiatry and its effects on cognition. Nat Rev Neurol 6, 5, 267-75.
108. Husain MM et al. (2008). The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 69, 3, 406-11.
109. Huuhka K et al. (2008). Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neurosci Lett 448, 1, 79-83.
110. Hu Y et al. (2010). The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J Ect 26, 2, 121-5.
111. Janicak PG et al. (2008). Transcranial magnetic stimulation in the treatment of major depressive disorder, a comprehensive summary of safety experience from acute exposure extended exposure and during reintroduction treatment. J Clin Psychiatry 69, 2, 222-32.
112. Janicak PG et al. (2010). Durability of clinical benefit with transcranial magnetic stimulation TMS in the treatment of pharmacoresistant major depression, assessment of relapse during a 6-month multisite open-label study. Brain Stimulation 3, 4, 187-199.
113. Johnson MD et al. (2008). Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics 5, 2, 294-308.
114. Johanson A et al. (2005). Long-term follow-up in depressed patients treated with electroconvulsive therapy. J Ect 21, 4, 214-20.
115. Juckel G A, Mendlin BL Jacobs (1999). Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output, implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 21, 3, 391-8.
116. Kellner CH et al. (2006). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression, a multisite study from the Consortium for Research in Electroconvulsive Therapy CORE. Arch Gen Psychiatry 63, 12, 1337-44.
117. Kellner CH, KG Tobias and J Wiegand (2010a). Electrode Placement in Electroconvulsive Therapy ECT, A Review of the Literature. J Ect 26, 3, 175-180.
118. Kellner CH et al. (2010b). Bifrontal bitemporal and right unilateral electrode placement in ECT, randomised trial. Br t Psychiatry 196, 226-34.
119. Kim EJ et al. (2006). Repetitive transcranial magnetic stimulation protects hippocampal plasticity in an animal model of depression. Neurosci Lett 405, 1-2, 79-83.
120. Kim DR, J Gonzalez and JP O'Reardon (2009). Pregnancy and depression, exploring a new potential treatment option. Curr Psychiatry Rep 11, 6, 443-6.
121. Kirov G et al. (2008). Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 193, 2, 152-5.
122. Kito S, K Fujita and Y Koga (2008). Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J Neuropsychiatry Clin Neurosci 20, 1, 74-80.
123. Kito S et al. (2010). Changes in hypothalamic-pituitary-thyroid axis following successful treatment with low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression. Psychiatry Res 175, 1-2, 74-7.
124. Klein E et al. (1999). Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression, a double-blind controlled study. Arch Gen Psychiatry 56, 4, 315-20.
125. Knoch D et al. (2006). Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. Neuroimage 31, 2, 641-8.
126. Ko D et al. (1996). Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H215O blood flow imaging. Neurosurgery 39, 2, 426-30; discussion 430-1
127. Kopell BH and BD Greenberg (2008). Anatomy and physiology of the basal ganglia, implications for DBS in psychiatry. Neurosci Biobehav Rev 32, 3, 408-22.
128. Kozel FA et al. (2009). Using simultaneous repetitive Transcranial Magnetic Stimulation/functional Near Infrared Spectroscopy rTMS/fNIRS to measure brain activation and connectivity. Neuroimage 47, 4, 1177-84.
129. Krahl SE et al. (1998). Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39, 7, 709-14.
130. Kraus T et al. (2007). BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 114, 1485-1493.
131. Kudo K et al. (2005). Repetitive transcranial magnetic stimulation induces kf-1 expression in the rat brain. Life Sci 76, 21, 2421-9.
132. Labiner DM and GL Ahern (2007). Vagus nerve stimulation therapy in depression and epilepsy, therapeutic parameter settings. Acta Neurol Scand 115, 1, 23-33.
133. Langguth B et al. (2007). Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation rTMS. Neuro Endocrinol Lett 28, 5, 633-8.
134. Lefaucheur JP et al. (2008). Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res 42, 5, 389-98.
135. Levkovitz Y et al. (2009). Deep transcranial magnetic stimulation over the prefrontal cortex, evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2, 4, 188-200.
136. Li W and B Olshansky (2010). Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 16, 2, 137-145.
137. Li X et al. (2004). Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry 55, 9, 882-90.
138. Lisanby SH and RH Belmaker (2000). Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation RTMS, comparisons with electroconvulsive shock ECS. Depress Anxiety 12, 3, 178-87.
139. Lisanby SH et al. (2003a). Safety and feasibility of magnetic seizure therapy MST in major depression, randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 28, 10, 1852-65.
140. Lisanby SH et al. (2003b). New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr 8, 7, 529-36.
141. Lisanby SH et al. (2009). Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression, clinical predictors of outcome in a multisite randomized controlled clinical trial. Neuropsychopharmacology 34, 2, 522-34.
142. Loo C et al. (2001). Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation rTMS on neuropsychologic functioning electroencephalogram and auditory threshold in depressed patients. Biol Psychiatry 49, 7, 615-23.
143. Loo CK et al. (2003). High 15 Hz and low 1 Hz frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients. Psychol Med 33, 6, 997-1006.
144. Loo CK et al. (2009). A double-blind sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 13, 1, 61-9.
145. Lozano AM et al. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64, 6, 461-7.
146. Luborzewski A et al. (2007). Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 41, 7, 606-15.
147. MacLean PD (1990). Triune brain in evolution, role in paleocerebral functions. Plenum Press, New York, NY.
148. Majoie HJ et al. (2010). Vagus Nerve Stimulation in Refractory Epilepsy, Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral Blood. Neuroimmunomodulation 18, 1, 5256.
149. Malone DA Jr et al. (2009). Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression. Biol Psychiatry 66, 4, 267-275.
150. Marangell LB et al. (2002). Vagus nerve stimulation VNS for major depressive episodes, one year outcomes. Biol Psychiatry 51, 4, 280-7.
151. Matthews JD et al. (2008). The impact of galantamine on cognition and mood during electroconvulsive therapy, a pilot study. J Psychiatr Res 42, 7, 526-31.
152. Mayberg HS et al. (1997). Cingulate function in depression, a potential predictor of treatment response. Neuroreport 8, 1057-61.
153. Mayberg HS (2002). Modulating limbic-cortical circuits in depression, targets of antidepressant treatments. Semin Clin Neuropsychiatry 7, 4, 255-68.
154. Mayberg HS (2003). Positron emission tomography imaging in depression, a neural systems perspective. Neuroimaging Clin N Am 13, 4, 805-15.
155. Mayberg HS et al. (2005). Deep brain stimulation for treatment- resistant depression. Neuron 45, 5, 651-60.
156. Mayur pet al. (2010). Impact of hyperventilation on stimulus efficiency during the early phase of an electroconvulsive therapy course, a randomized double-blind study. J Ect 26, 2, 91-4.
157. McCormick LM et al. (2009). Relative ineffectiveness of ultrabrief right unilateral versus bilateral electroconvulsive therapy in depression. J Ect 25, 4, 238-42.
158. McNeely HE et al. (2008). Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression, preliminary results over 12 months. J Nerv Ment Dis 196, 405-10.
159. Medda P et al. (2010). Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J Ect 26, 2, 82-6.
160. Meeus OM, D De Ridder and PH Van de Heyning (2009). Transcranial magnetic stimulation TMS in tinnitus patients. B-ENT 5, 2, 89-100.
161. Merkl AI, Heuser M Bajbouj (2009). Antidepressant electroconvulsive therapy, mechanism of action recent advances and limitations. Exp Neurol 219, 1, 20-6.
162. Mohan TS et al. (2009). Effects of stimulus intensity on the efficacy and safety of twice-weekly bilateral electroconvulsive therapy ECT combined with anti-psychotics in acute mania, a randomised controlled trial. Bipolar Disord 11, 2, 126-34.
163. Moscrip TD et al. (2006). Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy MST and electroconvulsive shock ECS. Int J Neuropsycho-pharmacol 9, 1, 1-11.
164. Murphy DN, P Boggio and F Fregni (2009). Transcranial direct current stimulation as a therapeutic tool for the treatment of major depression, insights from past and recent clinical studies. Curr Opin Psychiatry 22, 3, 306-11.
165. Nahas Z et al. (2001). Unilateral left prefrontal transcranial magnetic stimulation TMS produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry 50, 9, 712-20.
166. Nahas Z et al. (2003). Left prefrontal transcranial magnetic stimulation TMS treatment of depression in bipolar affective disorder, a pilot study of acute safety and efficacy. Bipolar Disord 5, 1, 40-7.
167. Nahas Z et al. (2005). Two-year outcome of vagus nerve stimulation VNS for treatment of major depressive episodes. J Clin Psychiatry 66, 9, 1097-104.
168. Nahas Z et al. (2007). Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsy- chopharmacology 32, 8, 1649-60.
169. Nahas Z et al. (2010). Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry 67, 2, 101-9.
170. Nakamura H et al. (1997). Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 49, 8, Pt 3, 817-23.
171. Naritoku DK, WJ Terry and RH Helfert (1995). Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 22, 1, 53-62.
172. Nemeroff CB et al. (2006). VNS therapy in treatment-resistant depression, clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31, 7, 1345-55.
173. Nestler EJ and WA Carlezon Jr (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59, 12, 11519.
174. Neuhaus AH et al. (2007). P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. J Affect Disord 100, 1-3, 123-8.
175. Nitsche MA et al. (2009). Treatment of depression with transcranial direct current stimulation tDCS, a review. Exp Neurol 219, 1, 14-9.
176. Nobler MS et al. (2001). Decreased regional brain metabolism after ect. Am t Psychiatry 158, 2, 305-8.
177. Nordanskog P et al. (2010). Increase in hippocampal volume after electroconvulsive therapy in patients with depression, a volumetric magnetic resonance imaging study. J Ect 26, 1, 62-7.
178. Nordenskjold A, LV Knorring and I Engstrom (2011). Rehospitalization rate after continued electroconvulsive therapy-A retrospective chart review of patients with severe depression. NordtPsychiatry 65, 1, 26-31.
179. Okamoto T et al. (2008). Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor BDNF in refractory depressed patients, a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 32, 5, 1185-90.
180. Ohnishi T et al. (2004). Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex, an (11C)raclopride positron emission tomography study in anesthetized macaque monkeys. Biol Psychiatry 55, 5, 484-9.
181. O'Reardon JP et al. (2007a). Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation rTMS are resistant to the effects of rapid tryptophan depletion. Depress Anxiety 24, 8, 537-44.
182. O'Reardon JP et al. (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression, a multisite randomized controlled trial. Biol Psychiatry 62, 11, 1208-16.
183. Pagnin D et al. (2004). Efficacy of ECT in depression, a meta- analytic review. J Ect 20, 1, 13-20.
184. Pallanti S et al. (2010). Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation, is simpler better for treatment of resistant depression?. Neuroscience 167, 2, 323-8.
185. Papacostas SS et al. (2007). Induction of central-type sleep apnea by vagus nerve stimulation. Electromyogr Clin Neurophysiol 47, 1, 61-3.
186. Pascual-Leone A and B Rubio (1996). Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortext in drug-resistant depression. Lancet 348, 9022, 233-7.
187. Pascual-Leone A et al. (1992). No evidence of hearing loss in humans due to transcranial magnetic stimulation. Neurology 42, 3, Pt 1, 647-51.
188. Petrides G et al. (2001). ECT remission rates in psychotic versus nonpsychotic depressed patients, a report from CORE. T Ect 17, 4, 244-53.
189. Picarelli H et al. (2010). Repetitive Transcranial Magnetic Stimulation is Efficacious as an Add-On to Pharmacological Therapy in Complex Regional Pain Syndrome CRPS Type I. J Pain 11, 11, 1203-1210.
190. Pogarell O et al. (2006). Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression, preliminary results of a dynamic (123I) IBZM SPECT study. J Psychiatr Res 40, 4, 307-14.
191. Pogarell O et al. (2007). Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. Psychiatry Res 156, 3, 251-5.
192. Post RM et al. (1998). A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology 38, 3, 152-66.
193. Pridmore S (1999). Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiatry Clin Neurosci 53, 1, 33-7.
194. Prudic J, S Peyser and HA Sackeim (2000). Subjective memory complaints, a review of patient self-assessment of memory after electroconvulsive therapy. JEct 16, 2, 121-32.
195. Prudic J et al. (2004). Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 55, 3, 301-12.
196. Quante A et al. (2011). Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression, A randomized double-blind pilot study. J Psychiatr Res 45, 2, 174.
197. Rauch SL et al. (2006). A functional neuroimaging investigation of deep brain stimulation in patients with obsessive- compulsive disorder. J Neurosurg 104, 4, 558-65.
198. Rigonatti SP et al. (2008). Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry 23, 1, 74-6.
199. Ring HA et al. (2000). A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure 9, 6, 380-4.
200. Rosa MA et al. (2006). Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression, a randomized single-blind study. Int t Neuropsychopharmacol 9, 6, 66776.
201. Rossi S et al. (2009). Safety ethical considerations and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 120, 12, 2008-39.
202. Rossini D et al. (2010). A symptom-specific analysis of the effect of high-frequency left or low-frequency right transcranial magnetic stimulation over the dorsolateral prefrontal cortex in major depression. Neuropsychobiology 62, 2, 91-7.
203. Roth BJ, LG Cohen and M Hallett (1991a). The electric field induced during magnetic stimulation. Electroencephalogr Clin Neurophysiol, Suppl 43, 268-78.
204. Roth BJ et al. (1991b). A theoretical calculation of the electric field induced in the cortex during magnetic stimulation. Electroencephalogr Clin Neurophysiol 81, 1, 47-56.
205. Rowny SB, K Benzl and SH Lisanby (2009a). Translational development strategy for magnetic seizure therapy. Exp Neurol 219, 1, 27-35.
206. Rowny SB et al. (2009b). Differential heart rate response to magnetic seizure therapy MST relative to electroconvulsive therapy, a nonhuman primate model. Neuroimage 47, 3, 1086-91.
207. Rudorfer MV, HK Manji, WZ Potter (1992). Monoaminergic actions of ECT. Clin Neuropharmacol 15, Suppl 1 Pt A, 677A-678A.
208. Rumi DO et al. (2005). Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression, a double-blind placebo-controlled study. Biol Psychiatry 57, 2, 162-6.
209. Rush AJ et al. (2005a). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression, a naturalistic study. Biol Psychiatry 58, 5, 355-63.
210. Rush AJ et al. (2005b). Vagus nerve stimulation for treatment-resistant depression, a randomized controlled acute phase trial. Biol Psychiatry 58, 5, 347-54.
211. Rush AJ et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps, a STAR*D report. Am tPsychiatry 163, 11, 1905-17.
212. Rusjan PM et al. (2010). Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp 31, 11, 1643-52.
213. Sachdev PS et al. (2002). Effects of different frequencies of transcranial magnetic stimulation TMS on the forced swim test model of depression in rats. Biol Psychiatry 51, 6, 474-9.
214. Sackeim HA et al. (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328, 12, 83946.
215. Sackeim HA et al. (2001). Vagus nerve stimulation VNS for treatment-resistant depression, efficacy side effects and predictors of outcome. Neuropsychopharmacology 25, 5, 713-28.
216. Sackeim HA et al. (2007a). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32, 1, 244-54.
217. Sackeim HA et al. (2007b). Durability of antidepressant response to vagus nerve stimulation VNS. Int J Neuropsy-chopharmacol 10, 6, 817-26.
218. Sackeim HA et al. (2008). Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul 1, 2, 71-83.
219. Sackeim HA et al. (2009). Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes, short-term efficacy and adverse effects. Arch Gen Psychiatry 66, 7, 729-37.
220. Saijo T et al. (2010). Electroconvulsive therapy decreases dopamine D2 receptor binding in the anterior cingulate in patients with depression, a controlled study using positron emission tomography with radioligand (11C)FLB 457. J Clin Psychiatry 71, 6, 793-9.
221. Sanacora G, GF Mason and JH Krystal (2000). Impairment of GABAergic transmission in depression, new insights from neuroimaging studies. Crit Rev Neurobiol 14, 1, 23-45.
222. Sanacora G et al. (2004). Subtype-specific alterations of gam-ma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61, 7, 705-13.
223. Sartorius A et al. (2007). Elevated spectroscopic glutamate/gam-ma-amino butyric acid in rats bred for learned helplessness. Neuroreport 18, 14, 1469-73.
224. Sartorius A et al. (2010). Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 67, 2, e9-e11.
225. Schlaepfer TE et al. (2007). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33, 2, 368-77.
226. Schutter DJ (2009). Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs, a meta-analysis. Psychol Med 39, 1, 65-75.
227. Schutter DJLG (2010). Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychological Medicine, First View article, 1-7.
228. Schutter DJ and J van Honk (2010). An endocrine perspective on the role of steroid hormones in the antidepressant treatment efficacy of transcranial magnetic stimulation. Psychoneuroendocrinology 35, 1, 171-8.
229. Segawa K et al. (2006). Regional cerebral blood flow changes in depression after electroconvulsive therapy. Psychiatry Res 147, 2-3, 135-43.
230. Semkovska M and DM McLoughlin (2010). Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression, A Systematic Review and Meta-Analysis. Biol Psychiatry 68, 6, 568-77.
231. Shin M and DM Chetkovich (2007). Activity-dependent regulation of h channel distribution in hippocampal CA1 pyramidal neurons. J Biol Chem 282, 45, 33168-80.
232. Sienaert P et al. (2005). Patient satisfaction after electroconvulsive therapy. J Ect 21, 4, 227-31.
233. Sienaert P et al. (2009). Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression, clinical efficacy. J Affect Disord 116, 1-2, 106-12.
234. Slotema CW et al. (2010). Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation rTMS? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 71, 7, 873-84.
235. Szuba MP et al. (2001). Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biol Psychiatry 50, 1, 22-7.
236. Takano H et al. (2007). Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression, positron emission tomographic study. Br J Psychiatry 190, 63-8.
237. Tanis KQ, RS Duman and SS Newton (2008). CREB binding and activity in brain, regional specificity and induction by electroconvulsive seizure. Biol Psychiatry 63, 7, 710-20.
238. Teneback CC et al. (1999). Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 11, 4, 426-35.
239. Tremblay LK et al. (2005). Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62, 11, 1228-36.
240. UK ECT Review Group (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders, a systematic review and meta-analysis. Lancet 361, 9360, 799-808.
241. Valdes-Cruz A et al. (2008). Long-term changes in sleep and electroencephalographic activity by chronic vagus nerve stimulation in cats. Prog Neuropsychopharmacol Biol Psychiatry 32, 3, 828-34.
242. Vamos M (2008). The cognitive side effects of modern ECT, patient experience or objective measurement?. J Ect 24, 1, 18-24.
243. van Beusekom BS, WW van den Broek and TK Birkenhager (2007). Long-term follow-up after successful electroconvulsive therapy for depression, a 4- to 8-year naturalistic follow-up study. J Ect 23, 1, 17-20.
244. Van Bockstaele EJ, J Peoples, RJ Valentino, and AE Bennett (1999). Research Award Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 46, 10, 1352-63.
245. Van Laere K et al. (2000). Vagus nerve stimulation in refractory epilepsy, SPECT activation study. J Nucl Med 41, 7, 114554.
246. Vonck K et al. (2000). Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia 41, 5, 601-9.
247. Vonck K et al. (2008). Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation a SPECT study. Seizure 17, 8, 699-706.
248. Walker BR, A Easton and K Gale (1999). Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40, 1051-1057.
249. Walpoth M et al. (2008). Repetitive transcranial magnetic stimulation in bulimia nervosa, preliminary results of a single-centre randomised double-blind sham-controlled trial in female outpatients. Psychother Psychosom 77, 1, 57-60.
250. Wang F et al. (2010). The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area. JMol Neurosci 41, 1, 145-55.
251. Warnell RL and N Elahi (2007). Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen, a case study and cost analysis. J Ect 23, 2, 114-9.
252. Wassermann EM (1998). Risk and safety of repetitive transcranial magnetic stimulation, report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation June 5-7 1996. Electroencephalogr Clin Neurophysiol 108, 1, 1-16.
253. Weiner RD and CE Coffey (1988). Indications for use of electroconvulsive therapy in AJ Frances and RE Hales (Eds) Review of Psychiatry. American Psychiatric Press Inc, Washington DC, 45881.
254. Xia G et al. (2008). Treatment-emergent mania in unipolar and bipolar depression, focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol 11, 1, 119-30.
255. Yatham LN et al. (2010). Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression. Br t Psychiatry 196, 6, 474-9.
256. Yildiz A et al. (2010). Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse, a pilot controlled trial. J Ect 26, 2, 104-10.
257. Yukimasa T et al. (2006). High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry 39, 2, 52-9.
258. Yuuki N et al. (2005). HPA axis normalization estimated by DEX/ CRH test but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatr Scand 112, 4, 257-65.
259. Zabara J (1985a). Control of hypersynchronous discharge in epilepsy. Electroencephalogr Clin Neurophysiol Suppl 61, S162.
260. Zabara J (1985b). Time course of seizure control to brief repetitive stimuli. Epilepsia 26, 518.
261. Zabara J (1992). Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33, 6, 1005-12.
262. Zanardini R et al. (2006). Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord 91, 1, 83-6.
263. Zangen A and K Hyodo (2002). Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport 13, 18, 2401-5.
264. Zobel A et al. (2005). Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression, an exploratory approach. Psychiatry Res 139, 3, 165-79.
265. Zuo Y, DC Smith and RA Jensen (2007). Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats. Physiol Behav 90, 4, 583-9.